Skip to content

Author

Xinyi Dang

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

BUB3: a novel prognostic biomarker and therapeutic target in hepatocellular carcinoma unveiled by pan-cancer analysis and experimental validation

It is demonstrated that BUB3 plays a critical role in tumor progression and immune regulation and possesses substantial diagnostic and prognostic value, highlighting its potential as both a biomarker for patient stratification and a promising therapeutic target across multiple cancer types.

Xiaona Liu, Yajie Qi, Xinyi Dang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.